CEO Kevin McNamara sells 2,000 shares at CHE; his sixth sale at this company in 36 months, continuing a pattern of net dispositions.
Kevin McNamara, Chemed's President and CEO, sold 2,000 shares, representing his sixth open-market sale at this company in the past 36 months. Over the same period, he has made no open-market purchases, painting a consistent picture of net selling. The stock currently trades well below its 52-week high, and the company remains profitable with solid revenue growth. McNamara's track record at Chemed has been mixed: at the 30-day horizon, three of his five prior sales saw the stock decline afterward (well-timed exits), while two saw gains (poorly-timed); at the 90-day horizon, only one of his five prior sales was followed by a decline, while four saw subsequent stock gains, meaning most prior exits were ultimately poorly timed. This ongoing sale comes at a time when the company's fundamentals remain intact, but the repeated selling pattern combined with mixed timing on prior exits suggests no clear conviction signal from the CEO level.